CompletedPhase 4NCT00628901
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Studying Muscular tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Scientific Corporation
- Principal Investigator
- Richard Shalansky-Goldberg, MDUniversity of Pennsylvania
- Intervention
- Uterine Fibroid Embolization (UFE)(procedure)
- Enrollment
- 60 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2006 – 2011
Study locations (1)
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00628901 on ClinicalTrials.govOther trials for Muscular tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07352761Bilateral Uterine Artery Occlusion During Laparoscopic MyomectomyAlexandria University
- RECRUITINGNANCT05683041Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic MyomectomyUniversity Hospital, Ghent
- ACTIVE NOT RECRUITINGNCT05607602Are Uterine Fibroids Pro-thrombotic?King's College Hospital NHS Trust